LUTREPULSE KIT Drug Patent Profile
When do Lutrepulse Kit patents expire, and what generic alternatives are available?
Lutrepulse Kit is a drug marketed by Ferring and is included in one NDA.
The generic ingredient in LUTREPULSE KIT is gonadorelin acetate. There is one drug master file entry for this compound. Additional details are available on the gonadorelin acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LUTREPULSE KIT?
- What are the global sales for LUTREPULSE KIT?
- What is Average Wholesale Price for LUTREPULSE KIT?
Summary for LUTREPULSE KIT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 66 |
| Clinical Trials: | 5 |
| Patent Applications: | 2,606 |
| DailyMed Link: | LUTREPULSE KIT at DailyMed |
Recent Clinical Trials for LUTREPULSE KIT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ferring Pharmaceuticals | PHASE1 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Early Phase 1 |
| Los Angeles Biomedical Research Institute | Early Phase 1 |
US Patents and Regulatory Information for LUTREPULSE KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | LUTREPULSE KIT | gonadorelin acetate | INJECTABLE;INJECTION | 019687-001 | Oct 10, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ferring | LUTREPULSE KIT | gonadorelin acetate | INJECTABLE;INJECTION | 019687-002 | Oct 10, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
